Intermittent androgen-deprivation therapy (ADT) seems be a well-accepted treatment modality and, by allowing discontinuation of androgen-suppression and recovery of the testosterone, reduces the side-effects of treatment. Clearly it is not suitable for all men, but one of the randomised trials of intermittent ADT (New England Journal of Medicine 2012;367:895-903)in men with raised PSA after primary or salvage radiotherapy, and no metastases, showed that the risk of death was the same as with continuous treatment but quality of life was better.
I do not get the impression, though, that there are many men on intermittent ADT in the centre where I am being treated. I have also noticed the results of a recently published survey (ESMO Open 2016;1:e000040) which showed that there were significant variations in the proportion of patients receiving intermittent ADT in different countries: in the UK only 10% of patients in this survey had intermittent ADT, as opposed to 35% in Australia and France, 32% in Canada and Germany, and 26% in the USA.
Is it difficult to get intermittent ADT in the UK?